{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:45:30Z","timestamp":1775605530384,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C7852\\u2013A25447"],"award-info":[{"award-number":["C7852\\u2013A25447"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejso.2026.111411","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:01:57Z","timestamp":1768582917000},"page":"111411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reducing locoregional treatments in low risk early invasive breast cancer"],"prefix":"10.1016","volume":"52","author":[{"given":"Shelley","family":"Potter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mairead","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-1535","authenticated-orcid":false,"given":"Toral","family":"Gathani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5197-7511","authenticated-orcid":false,"given":"Sileida","family":"Oliveros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dodwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.111411_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074684","article-title":"Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study","volume":"381","author":"Taylor","year":"2023","journal-title":"Br Med J"},{"key":"10.1016\/j.ejso.2026.111411_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.breast.2022.01.012","article-title":"Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review","volume":"62","author":"Yussof","year":"2022","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.ejso.2026.111411_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"32","key":"10.1016\/j.ejso.2026.111411_bib4","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2026.111411_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.111411_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110372","article-title":"Quality assessment of radiotherapy in the prospective randomized SENOMAC trial","volume":"197","author":"Alkner","year":"2024","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111411_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1470-2045(24)00661-2","article-title":"Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial","volume":"26","author":"Meattini","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111411_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-022-06756-4","article-title":"Identifying research priorities in breast cancer surgery: a UK priority setting partnership with the James Lind Alliance","volume":"197","author":"Potter","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.ejso.2026.111411_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.clon.2019.05.008","article-title":"The SMALL trial: a big change for small breast cancers","volume":"31","author":"Morgan","year":"2019","journal-title":"Clin Oncol"},{"issue":"15","key":"10.1016\/j.ejso.2026.111411_bib10","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.3390\/diagnostics13152595","article-title":"The applications of high-intensity focused ultrasound (HIFU) ablative therapy in the treatment of primary breast cancer: a systematic review","volume":"13","author":"Zulkifli","year":"2023","journal-title":"Diagnostics"},{"issue":"11","key":"10.1016\/j.ejso.2026.111411_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.111411_bib12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary surgery in breast cancer\u2014primary results of the INSEMA trial","volume":"392","author":"Reimer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejso.2026.111411_bib13","unstructured":"https:\/\/tadpole.blogs.bristol.ac.uk."}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:50:15Z","timestamp":1775602215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0748798326000302"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111411","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reducing locoregional treatments in low risk early invasive breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111411"}}